Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Opioids
281 - 300 of 381 Results
-
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 A Detour On A Smoking Off-Ramp
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Sarah Jane Tribble of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call talk about the Food and Drug Administration鈥檚 latest actions to address teenagers鈥 use of e-cigarettes, Arkansas鈥 Medicaid work requirements and news about the uninsured from the latest federal Census report.
-
Insurer To Purdue Pharma: We Won’t Pay For OxyContin Anymore
Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
States Looking To Tax Opioids Pin Hopes On November Elections
At least 11 states are going to try to tax opioids despite pushback from pharmaceutical companies.
By Jay Hancock and Shefali Luthra -
Giuliani鈥檚 Consulting Firm Helped Halt Purdue Opioid Investigation In Florida
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue鈥檚 marketing of OxyContin.
By Fred Schulte -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Suicide By Opioid: New Research Suggests Overdoses Should Be Classified As Self-Harm
Researchers combined the number of suicide deaths with those associated with drug overdoses in an effort to better grasp the overlap between these two public health epidemics.
By Rachel Bluth -
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Opioids, EpiPens And Health Funding
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?
-
Babies Dependent On Opioids Need Touch, Not Tech
One doctor in Kansas works to make sure every hospital in the state can provide the soft start, ideally with their mothers, that babies with neonatal abstinence syndrome need.
-
Purdue Pharma’s Sales Pitch Downplayed Risks Of Opioid Addiction
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients鈥 right to opioid treatment for pain.
By Fred Schulte -
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 See You In Court!
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about a spate of lawsuits involving the Affordable Care Act, as well as the latest in state and federal efforts regarding the Medicaid program for the poor.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Clinicians Who Learn Of A Patient鈥檚 Opioid Death Modestly Cut Back On Prescriptions
A study published Thursday shows that doctors, dentists and other medical providers cut overall opioid dosages by nearly 10 percent after receiving notification of a death from a medical examiner and information on safe prescribing.
By Anna Gorman -
As Opioid Crisis Rages, Some Trade 鈥楾ough Love鈥 For Empathy
An approach known as Community Reinforcement and Family Training, or CRAFT, coaches families to deal with a loved one's substance abuse with compassion.
-
Listen: Inexpensive Nerve Drug Often Abused As Opioid Epidemic Grows
Gabapentin, a medication approved to help patients with nerve pain or epilepsy, is being abused by people addicted to opioids to help prolong their high or stave off withdrawal from other drugs. Kaiser Health News reporter Carmen Heredia Rodriguez talks about the problem during a wide-ranging health discussion on the NPR program "On Point."
-
How Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin鈥檚 Dangers
Fentanyl and other painkillers marketed as safer than Purdue Pharma鈥檚 blockbuster drug left their own trail of overdose deaths.
By Fred Schulte -
Patients With Chronic Pain Feel Caught In An Opioid-Prescribing Debate
States are passing laws that limit a doctor's ability to prescribe opioids. Doctors and patients alike are wrestling with what that means in cases of chronic pain.
-
Readers And Tweeters: On Seniors Packing Heat And When They Should Pack It In
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Purdue Pharma Edits Public Service Ad In Washington Post
Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed 鈥 then walk it back?
By Fred Schulte